Adage Capital Partners GP »

Immix Biopharma shares owned by Adage Capital Partners GP

Quarter-by-quarter ownership of Immix Biopharma (IMMX) shares owned by Adage Capital Partners GP from 13F filings

Historical chart of Adage Capital Partners GP investment in Immix Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Immix Biopharma held by Adage Capital Partners GP consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immix Biopharma by Adage Capital Partners GP

Quarter filed Position value Share count Share price at filing
2025-12-31 $7.8M 1.5M 5.23

More positions owned by Adage Capital Partners GP

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
ConocoPhillips (COP)
Visa Com Cl A (V)
Johnson & Johnson (JNJ)

View all positions for Adage Capital Partners GP

Top funds holding Immix Biopharma

Saturn V Capital Management
Eventide Asset Management
Marshall Wace
Millennium Management
Adage Capital Partners GP
Vanguard Group
Logos Global Management
Bleichroeder
Blue Owl Capital Holdings
Franklin Resources
Susquehanna International
Ameriprise Financial
Perceptive Advisors
Burkehill Global Management
Renaissance Technologies

View all funds holding Immix Biopharma